Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when BBNX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsBeta Bionics shareholders elect directors, ratify Ernst & Young at annual meeting
Filed May 22, 2026 · Period ending May 21, 2026 · ~1 min read
Key Changes
-
low
Shareholders elected Sean D. Carney (98.1% of votes cast, 68.8% of shares outstanding) and Christy Jones (82.7% of votes cast, 58.0% of shares outstanding) as Class I directors to serve until 2029.
Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR → -
low
Ernst & Young LLP ratified as independent auditor for fiscal 2026 with 99.9% approval (36,011,432 for, 41,527 against, 8,089 abstentions), representing 80.8% of shares outstanding.
Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR → -
low
Meeting achieved quorum with 36,061,048 shares (80.9%) of 44,561,695 outstanding shares represented in person or by proxy.
Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
Summary
Beta Bionics held its 2026 annual meeting on May 21, reporting routine governance outcomes. Shareholders elected two Class I directors with strong support: Sean D. Carney received 98.1% approval of votes cast (30,659,060 for vs. 608,992 withheld), while Christy Jones received 82.7% (25,865,542 for vs. 5,402,510 withheld). Both will serve three-year terms through 2029.
The auditor ratification passed with near-unanimous support at 99.9%. For retail holders, this is a routine compliance disclosure with no material impact on operations or strategy. The voting results reflect normal shareholder engagement, with quorum achieved at 80.9% of outstanding shares and no contested proposals. The filing documents standard annual meeting mechanics required by securities regulations.
Section-by-Section Diff
Event · Item 5.07 — Submission of Matters to a Vote of Security Holders
Beta Bionics held its 2026 annual meeting, electing two directors and ratifying Ernst & Young as auditor with strong shareholder support.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Name | of Director | Votes | For | Votes | Withheld | Broker | Non-Votes Sean D. Carney 30,659,060 | 608,992 | 4,792,996 Christy Jones | 25,865,542 | 5,402,510 | 4,792,996
Shareholders elected Sean D. Carney and Christy Jones as Class I directors to serve until the 2029 annual meeting. Carney received 98.1% support (30,659,060 for vs. 608,992 withheld) and Jones received 82.7% support (25,865,542 for vs. 5,402,510 withheld) of votes cast. Against the 44,561,695 shares outstanding, Carney received 68.8% support and Jones received 58.0% support.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 21, 2026 · How we verify